Technetium-99m tetrofosmin uptake in lung cancer: comparison with thallium-201

Ann Nucl Med. 1996 Feb;10(1):143-5. doi: 10.1007/BF03165069.

Abstract

Technetium-99m tetrofosmin and thallium-201 lung SPECT imaging were performed in a patient with adenocarcinoma of the lung. Significant activities in the lung lesion were clearly depicted on both technetium-99m tetrofosmin and thallium-201 SPECT imaging. The early uptake, delayed uptake ratios and retention indices of the tumor were 2.75, 2.39 and -1.31 for thallium-201 imaging and 3.09, 2.27 and -26.5 for technetium-99m tetrofosmin imaging, respectively. This preliminary report suggests that technetium-99m tetrofosmin may have potential as a tumor imaging agent.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Aged
  • Evaluation Studies as Topic
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Male
  • Organophosphorus Compounds*
  • Organotechnetium Compounds*
  • Thallium Radioisotopes*
  • Tomography, Emission-Computed, Single-Photon / methods*
  • Tomography, X-Ray Computed

Substances

  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Thallium Radioisotopes
  • technetium tc-99m tetrofosmin